ã¡ãã£ã¢èšäº
ã³ããå€ç°æ ªã«æ°åç§°ãã¢ã«ãã¡ãªã©ã®ãªã·ã£æåã«ãïŒ·ïŒšïŒ¯ãæ±ºå®
ããºãææ°ããŒã¯ 561
twitterã³ã¡ã³ã 168ä»¶äž 1ïœ100ä»¶
æ¢ã«ãåç¥ããšæããŸãããcovid19 ã®ããã«åºå®ã®å°åãä»ããã¢ã«ãã¡ãããåŒç§°ã«ãããããªå£°æãwhoããã§ãŠãŸãã
ãã®æãšåæ§é ãã«å€±ããæããããŸãã
ãã®æãšåæ§é ãã«å€±ããæããããŸãã
ã
âãã«ã¿åïŒã€ã³ãã§æåã«ç¢ºèªïŒ
âã¢ã«ãã¡åïŒã€ã®ãªã¹ã§æåã«ç¢ºèªïŒ
âããŒã¿åïŒåã¢ããªã«ã§æåã«ç¢ºèªïŒ
âã¬ã³ãåïŒãã©ãžã«ã§æåã«ç¢ºèªïŒ
âãã«ã¿åïŒã€ã³ãã§æåã«ç¢ºèªïŒ
âã¢ã«ãã¡åïŒã€ã®ãªã¹ã§æåã«ç¢ºèªïŒ
âããŒã¿åïŒåã¢ããªã«ã§æåã«ç¢ºèªïŒ
âã¬ã³ãåïŒãã©ãžã«ã§æåã«ç¢ºèªïŒ
äžåœå
񇜆
ã®åå¡ã«åŸ¹ããWHO
äžçä¿å¥æ©é¢ïŒïŒ·ïŒšïŒ¯ïŒã¯ïŒïŒæ¥ããæžå¿µããããæ°åã³ãããŠã€ã«ã¹å€ç°æ ªïŒçš®é¡ã®åç§°ã«ã€ããŠãã®ãªã·ã£èªã®ã¢ã«ãã¡ãããã䜿çšãããšçºè¡šããã
ã¢ã«ãã¡ãããŒã¿ã
ã¬ã³ã âŠ
( ÂŽ_ã`) (ÂŽ<_ïœ ) ãªãã ã
/ , __/  /  ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄
ã»ã»ã»
ïŸïœªïŸïœŒ"
( ÂŽ <_ïœ)  ( ÂŽ <_ïœ)
/ , __/  / _/  ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄
ã¬ã³ã âŠ
( ÂŽ_ã`) (ÂŽ<_ïœ ) ãªãã ã
/ , __/  /  ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄
ã»ã»ã»
ïŸïœªïŸïœŒ"
( ÂŽ <_ïœ)  ( ÂŽ <_ïœ)
/ , __/  / _/  ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄
ãã«ã¿ïŒæ§ç§°ã€ã³ãæ ªïŒãäžçªãã°ãã®ããªïŒ â
5/31ããå€ãã£ãããã§ãã
ä»åŸå€ç°æ ªã®åºçŸãå€ãããŠïŒäœ¿ããã®ãªã·ã£æåãç¡ããªãããšããªããã°ããã®ã§ãããã
ãšããããããããããã£ãŠãå±éºãªã®ã¯ïŒã€ãããã
ã¬ã³ãã ã¿ããã ãªâŠ
ãŠã€ã«ã¹ãæåã«æ€åºãããåœãå°åã®åç§°ãçšããããšã§ããã€ãã¹ã®ã€ã¡ãŒãžãæ€ãä»ããããªããšèª¬æãã
ãªãã ããªãããããäžåœçºã®ã³ãããããªãã£ãããããã話ãåºãŠããªãã£ããšæãããããWHOãžã®äžä¿¡æãæããªããªã
åœåã§è¡šçŸãããã³ããå€ç°æ ª
ããããã®ãªã·ã¢èªã®ã¢ã«ãã¡ãããã«çœ®ãæããããã
ããã¯è¯ãã¢ã€ãã¢ð
å€ç°æ ªã«äœ¿ãããåœã¯æ°ã®æ¯ã ã£ãããâŠ
ã€ã³ãããã©ãžã«ã¯ãçžåœã€ã¡ãŒãžãäžãã£ãâŠð£
æ¥æ¬åã ã£ãŠããã€çºçãããåãããªãâŠ
ãã ãèŠããããããªâŠâð
ããããã®ãªã·ã¢èªã®ã¢ã«ãã¡ãããã«çœ®ãæããããã
ããã¯è¯ãã¢ã€ãã¢ð
å€ç°æ ªã«äœ¿ãããåœã¯æ°ã®æ¯ã ã£ãããâŠ
ã€ã³ãããã©ãžã«ã¯ãçžåœã€ã¡ãŒãžãäžãã£ãâŠð£
æ¥æ¬åã ã£ãŠããã€çºçãããåãããªãâŠ
ãã ãèŠããããããªâŠâð
å€ç°æ ªã«ã®ãªã·ã£ç¥è©±ã®ç¥ã®ååãã€ããæ¹åŒã¯ããã«ãªã£ãããã§ãããå¿æ¹ããããã®ããããŸãã
ãè¿ã¥ããªã俺ã®äœã«ã¯ä»ããŒãŠã¹ã宿ã£ãŠãããä¿ºã«æ¥è§Šãããã貎æ§ããã ã§ã¯ããŸããïŒã
ãè¿ã¥ããªã俺ã®äœã«ã¯ä»ããŒãŠã¹ã宿ã£ãŠãããä¿ºã«æ¥è§Šãããã貎æ§ããã ã§ã¯ããŸããïŒã
倧å
ã® ã§ãã
ã¯äœãŠèšãã®ïŒ
#
ã¯äœãŠèšãã®ïŒ
#
å
ã®å°åãåãã£ãã»ããå
¥åœå¶éã®ç®¡çäžåãããããããã«æããã©ããWHOã®ããããšã¯æ¬åœã«äžå¯è§£ã
ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªããæ¬¡åºãŠããæ ªã¯ãšãã·ãã³æ ªã«ãªããã©ãèšãã«ãããªã
ã³ããå€ç°æ ªãã¬ã³ãã ã¯ãŒã«ãã«çªå
¥ïŒ
ããã§ã¯ã
ã®ãªã·ã£ç¥è©±ã®ç¥ã®ååãªã©ãåè£ã«æãã£ãŠããããã§ããã§ããå€ãããã©ã³ãã瀟åãªã©ã«äœ¿ãããŠããããšãããèŠéãããŸãããé³¥ã®åŠåãªã©åæ€ç©åã«æ²¢å±±äœ¿ãããŠããããããããã§ããã©ãæ®å¿µã
æ±äº¬æ ªã¯ããšãã·ãã³ãã«ãªãæš¡æ§
å°æ± çŸååã®ãã åã¯ããšãã·ãã³ãã°ãããã«ãªãèŠèŸŒã¿
å°æ± çŸååã®ãã åã¯ããšãã·ãã³ãã°ãããã«ãªãèŠèŸŒã¿
ã€ãŸããã¢ã«ãã¡ã§ãããªã¡ã¬ã
ç
åã人åå°åããç
æ
ççããåœåããã®ãäž»æµã«ãªã£ãŠãããã€ã³ãã«ãšã³ã¶å€ç°æ ªã ã£ãŠæååããH1N1çãšä»ããŠããã ãã劥åœãããªãããå人çã«ã¯L452Rçãšå€ç°ç®æã§è¡šãã°ãããšæãããäžæçã«å®ãŸããã
ãã©ã€ã¢ã¹ã®ã¹ããŒãžåããèªããªãã®ã«ãã
仿Žã
åããé£ãã ãã
äžåœããæèéžããããšå¿ æ»ã§ããã ãããããå ããããŠæŠæŒ¢ãŠã£ã«ã¹ã§è¯ãã§ããã
äœã§ãããªäžå ±ã«å¥œãåæãããŠãŸã å¿åºŠããªããšãããªããã ã
åããé£ãã ãã
äžåœããæèéžããããšå¿ æ»ã§ããã ãããããå ããããŠæŠæŒ¢ãŠã£ã«ã¹ã§è¯ãã§ããã
äœã§ãããªäžå ±ã«å¥œãåæãããŠãŸã å¿åºŠããªããšãããªããã ã
ãã®ãªã·ã£ç¥è©±ã®ç¥ã®ååãªã©ãåè£ã«äžãã£ãŠãããã®ã®âŠããã»ã€ãã³æ ªãšãã¢ãããã£ãŒãæ ªãšãããã¥ãŒã¹ã§èªã¿äžããããã®ãæ³åãããšã·ã¥ãŒã«ã ãªã
WHOãå°çް工ãå§ãããå€ç°ãªãã³ãããŠã€ã«ã¹ã§ã¯æ°å€ã§ããããããå°œãããçºçå Žæã§ã¯ãªããçºèŠã§ããæè¡åã®ããåœãšããŠå®çŸ©ããã°è¯ãã®ã ãã ã£ãã
WHOã¯åžžã«äžåœã ãé æ ®ããä»åŸãå€ãããªãã
WHOã¯åžžã«äžåœã ãé æ ®ããä»åŸãå€ãããªãã
ãŠã€ã«ã¹ã«åœåã»å°åãã€ããããã®ããããªã«äžåèªããïŒ ã¹ãã€ã³é¢šéªãšãMERS(äžæ±åŒåžåšçå矀ïŒãšãçºçæºãšãæµè¡å°ã®åç§°ãã€ããŠããšãæŽå²çã«ããããããããšæããã ãâ¯
æŽå²ã«åãæ®ããªããèµ·æºã䞻匵ã§ããããåç§°ãã€ããŠãããããåœãšãããããã
æŽå²ã«åãæ®ããªããèµ·æºã䞻匵ã§ããããåç§°ãã€ããŠãããããåœãšãããããã
ãä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªãããã·ã³ãã«ãããŠæ
£ãããŸã§ã¯ãããããããå°åããã¯ãã£ãšããã®ã§ã¯ãïŒ
ã³ã³ã³èºçãšãããèšãèãåé¡ã«ãªã£ãããª
ãã®ãªã·ã£ç¥è©±ã®ç¥ã®ååãªã©ãåè£ã«äžãã£ãŠãããã®ã®ãå€ãããã©ã³ãã瀟åãªã©ã«äœ¿çšãããŠããããšããããèŠéãããã
ããããã
éèŠãªã®ã¯ããèµ·æºãã ãããïŒ
ãã£ãã調æ»ãé¡ãããŸããWHOããã
éèŠãªã®ã¯ããèµ·æºãã ãããïŒ
ãã£ãã調æ»ãé¡ãããŸããWHOããã
è±åœæ ªâã¢ã«ãã¡
åã¢ããªã«æ ªâããŒã¿
ãã©ãžã«æ ªâã¬ã³ã
ã€ã³ãæ ªâãã«ã¿
ãŸã æ £ããªããã©ãèŠããããé¢åã ãããšãã£ãŠä»è ã䟮蟱ãããããªåŒã³æ¹ã®ãŸãŸã§ã¯é§ç®ã ã
åã¢ããªã«æ ªâããŒã¿
ãã©ãžã«æ ªâã¬ã³ã
ã€ã³ãæ ªâãã«ã¿
ãŸã æ £ããªããã©ãèŠããããé¢åã ãããšãã£ãŠä»è ã䟮蟱ãããããªåŒã³æ¹ã®ãŸãŸã§ã¯é§ç®ã ã
ã€ã®ãªã¹åâã¢ã«ãã¡ãåã¢ããªã«åâããŒã¿ããã©ãžã«åâã¬ã³ããã€ã³ãåâãã«ã¿ãšèšãæãããšãæŠæŒ¢ãŠã€ã«ã¹ã®åŒç§°ãæåŠããã©ããã®åœã ããç®ç«ããªãããã«ãããšã®æ¿æ²»çå§åã ãªãïœ
[ã¿ã¬]WHOãæ°åã³ããå€ç°æ ªãåœåãããã¢ã«ãã¡ããããŒã¿ãã®åŒç§°ã«çœ®ãæã: ïŒ ä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªãã
ãä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªããã
ããŠã€ã«ã¹ãæåã«æ€åºãããåœãå°åã®åç§°ãçšããããšã§ããã€ãã¹ã®ã€ã¡ãŒãžãæ€ãä»ããããªãã
é ãïŒ
ããŠã€ã«ã¹ãæåã«æ€åºãããåœãå°åã®åç§°ãçšããããšã§ããã€ãã¹ã®ã€ã¡ãŒãžãæ€ãä»ããããªãã
é ãïŒ
ä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªãã
ãã£ã€ãæ ªã¯äœã«ãªãã®ïŒ
ãã£ã€ãæ ªã¯äœã«ãªãã®ïŒ
å·®å¥é²æ¢ã®æå³ã¯ãããããããαãã©ãã§Î²ãã©ãããããã«ãããªã
âš
âš
ãã€ããªããåã®å Žåã¯Î±Îã«ãªãã®ïŒïœ
ãïŒïŒ¯ïŒŽïŒšïŒ¥ïŒ²ïŒãã®ïŒ°ïŒ³ïŒ©ãæãåºãããΩãšãçžåœåŒ·åã ããªã
ããããããªãªãžãã«ã®æŠæŒ¢è¬¹è£œã®ãŠã€ã«ã¹ã«ã¯ä»ããªãã®ããïŒ
ã³ãã å€ç°æ ªã«æ°åç§°ãã¢ã«ãã¡ãªã©ã®ãªã·ã£æå㫠決å®
ãã£ã¡ãè²ããªã®ãªã·ã£æåã®åœ¢åã«å€æŽãããŠããã
/
/Tracking SARS-CoV-2 variants
/
/Tracking SARS-CoV-2 variants
å°é¢šã®åŒã³åã¿ãããªããã«ã¯ãããªããããã£ã±ãïŒ
ã§ãæŠæŒ¢ãŠã€ã«ã¹ã¯äœã«ãªãã®
ããããæŠæŒ¢æ ªã¯äœã«ãªãã®ïŒ
ãä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªããã
ãã€ãŠããªã³ã¹ãèšå·ã«ãªã£ã¡ãã£ãæã¿ããã«ããã€ãŠã€ã³ãæ ªãšåŒã°ããŠããã³ããå€ç°çš®ãã¿ãããªèšãæ¹ããã§ããªããšæããª
ãããã«ãããïŒïŒ
ãã©ãžã«æ ªã¯ã¬ã³ãç·ãåºãŠããã®ã§å±éºïŒÂŽïœ¥Ï`ïŒãšããã話ãåºãŠããŠä¿¡ãã人ãçŸãããããŸãããã
> è±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªã
äžåœæ ªã¯ïŒ
äžåœæ ªã¯ïŒ
ã2ãããŒããŒã¯ãã®è©±é¡ ã«å¯Ÿããã¢ããã€ã€ããã«ïŒããã«ã¯Î³é¢é£ã ããã®ãªã·ã£æåïŒã®ã飿 ã
ãŸãæ£éšãžã®å¹¹çްèç§»æ€çæ³ã¯ããæ³šå°ïŒåºããã倧äºãªæã«ãµããã¬ã€ãã¹ã®ãµã¹éЬåã®ã飿 ã
ãªã®ã ããããã¢ãªã³ã°ã¿ã¯ãé¢é£ã¯ã飿 ããæãã¯ãã
ãŸãæ£éšãžã®å¹¹çްèç§»æ€çæ³ã¯ããæ³šå°ïŒåºããã倧äºãªæã«ãµããã¬ã€ãã¹ã®ãµã¹éЬåã®ã飿 ã
ãªã®ã ããããã¢ãªã³ã°ã¿ã¯ãé¢é£ã¯ã飿 ããæãã¯ãã
è²ã®æ¹ãåºæåè©ãé¿ãã€ã€æŽŸçïŒéâèïŒã衚çŸã§ããŠãããããããã¿ãŒã³éïŒããã§ããŠããŸããã©ãããŒã§ãæç³»åã衚çŸã§ããªãã®ãã
è²ã®æ¹ãåºæåè©ãé¿ãã€ã€æŽŸçïŒéâèïŒã衚çŸã§ããŠãããããããã¿ãŒã³éïŒããã§ããŠããŸããã©ã
ã€ã³ãã«ãšã³ã¶ã®éŠæž¯åãšããœé£åã¯ããããïŒãœé£ã¯ãããªããã©ãã®ãªã·ã£æå䜿ãã®ãã®ãªã·ã£ã«å€±ç€Œã ãçºçæºã®ã€ãŒã¢ã«ãµã³ã¹ãŒåã«ããã°ããã®ã«
WHOã®æ¹éãšããŠãäžè²«ããŠãããç¹å®ã®åœããã®å
¥åœã ãå¶éããã°ãããšããåéããé²ãæå³ã§ãæå¹ãªãã ãã©ãã¡ãã£ã¢ã¯äœ¿ããªãã ãããªãå°ãªããšãïŒã€ã³ãæ ªïŒã¿ããã«äœµèšããã ããã
ã
ã
劥åœã§ããããŸãããŒãžã§ã³ãã³ããŒåŒã«ããã°å€ç°å
ã®å€å¥ãããããšãå¯èœã§ã¯ç¡ãããšãæããŸããã
è±åœæ ªã¯ã¢ã«ãã¡ã
åã¢ããªã«æ ªã¯ããŒã¿ã
ãã©ãžã«æ ªã¯ã¬ã³ãã
ã€ã³ãæ ªã¯ãã«ã¿
åã¢ããªã«æ ªã¯ããŒã¿ã
ãã©ãžã«æ ªã¯ã¬ã³ãã
ã€ã³ãæ ªã¯ãã«ã¿
ä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªãã
宮沢賢治ã®ã·ã°ãã«ãšã·ã°ãã¬ã¹ã¿ããããã
宮沢賢治ã®ã·ã°ãã«ãšã·ã°ãã¬ã¹ã¿ããããã
ãæžå¿µããããæ°åã³ãããŠã€ã«ã¹å€ç°æ ªïŒçš®é¡ã®åç§°ã«ã€ããŠãã®ãªã·ã£èªã®ã¢ã«ãã¡ãããã䜿çšãããšçºè¡šãä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªãã
ã¢ã«ãã¡ãããã§è¶³ãããããªã
ãåã¯èª°ã 俺ã®äžã®ä¿º
çµå±å Žæã®ååã§åŒã¶ã®ãäžçªéŠŽæã¿ããããã ãããªãã§é ãªã«å Žæã®ååãå«ãªãã ãïŒå°æ¥çã«æ¥æ¬æ ªãšãåºæ¥ããå«ã ãªãã£ãŠæãããïŒç§ã¯å
šç¶æããªãããå«ã ãšæã£ãŠããã®ã¯äœåŠãã®èª°ãããã ããããïŒ
ã¬ã«ãã«ãã£ããªãã¯ãã£ã¢ã¹ããŒãŒã¿ããã¥ãŒãã¯ã¹ã£ãŒã
ã€ãšãºã¹äŒïŒ·ïŒšïŒ¯:
ã³ããå€ç°æ ªïŒçš®é¡ã®åç§°ãã®ãªã·ã£èªã¢ã«ãã¡ãããã«
è±åœæ ª- αã¢ã«ãã¡Î 1
åã¢ããªã«æ ª- βããŒã¿Î 2
ãã©ãžã«æ ª- γã¬ã³ãÎ 3
ã€ã³ãæ ª- ÎŽãã«ã¿Î 4
ã®ãªã·ã£ç¥è©±ã®ååãåè£ã ã£ããããã©ã³ãã瀟åãªã©ã«äœ¿çšãããŠããããšãããèŠéãããã
ã³ããå€ç°æ ªïŒçš®é¡ã®åç§°ãã®ãªã·ã£èªã¢ã«ãã¡ãããã«
è±åœæ ª- αã¢ã«ãã¡Î 1
åã¢ããªã«æ ª- βããŒã¿Î 2
ãã©ãžã«æ ª- γã¬ã³ãÎ 3
ã€ã³ãæ ª- ÎŽãã«ã¿Î 4
ã®ãªã·ã£ç¥è©±ã®ååãåè£ã ã£ããããã©ã³ãã瀟åãªã©ã«äœ¿çšãããŠããããšãããèŠéãããã
[ã¿ã¬]WHOãæ°åã³ããå€ç°æ ªãåœåãããã¢ã«ãã¡ããããŒã¿ãã®åŒç§°ã«çœ®ãæã
ä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªãã
ä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªãã
ã³ããΊ
ã³ããÏ
ã³ããÎ
ã³ããΚ
ã³ããΩ
ãšãã«ãªãã®ããªïŒ
ã³ããÏ
ã³ããÎ
ã³ããΚ
ã³ããΩ
ãšãã«ãªãã®ããªïŒ
æŠæŒ¢æ ªãããã¢ã«ãã¡ã§ããåŸã«ãªã¡ã¬ãšããªãã®ã
ãããŠãããªã±ãŒã³ãå°é¢šåäœã®ãããªåã©ãã®ååã§ãã€ããã°è¯ãã®ã«ã
ã¢ããŒãããªãŒãã·ã³ãã£ããã³ã¹ã±ããããã
ã¢ããŒãããªãŒãã·ã³ãã£ããã³ã¹ã±ããããã
ãæŠæŒ¢ãŠã€ã«ã¹ããšããåŒç§°ã¯ïŒ®ïŒ§ãšããäºã§ãCOVID-19ãšãæ°åã³ãããšãåŒã¶ããã«ããçã§ãå ±éå瀟ã解説ããŠããã
ãšããããå€ç°æ ªã«ã€ããŠã¯ã仿¥ã«è³ããŸã§çã£ç«¯ããåœåã€ããŠå ±éâŠ
ãšããããå€ç°æ ªã«ã€ããŠã¯ã仿¥ã«è³ããŸã§çã£ç«¯ããåœåã€ããŠå ±éâŠ
åããããããªã£ãŠãããšæããä»åŸå€ç°æ ªãå¢ããŠã察å¿ã§ãããã
WHOã¯æ¥æ¬ã®ã¡ãã£ã¢ã«å³ããæå°ããé¡ãããŸããä»åã®åç¹ã®ãã£ã€ãã¯å
šã䜿çšãããå€ç°çš®ã¯çºèŠãããåœãããããããšäœ¿çšããŠããŸãã
æ¥æ¬ã®ã¡ãã£ã¢ã¯Wã¹ã¿ã³ããŒãã§ãããå€±æ Œã§ãã
æ¥æ¬ã®ã¡ãã£ã¢ã¯Wã¹ã¿ã³ããŒãã§ãããå€±æ Œã§ãã
WHOã§å·®å¥ã«ã€ãªããã®ã§ç¹å®å°åã®ã³ããå€ç°æ ªã®åŒç§°ãã¢ã«ãã¡ããŒã¿ãšåŒã¶ããšãæšå¥šããŠãããããã ãã©ãªã¡ã¬æ ªãšããã£ã¡ã匷ãããããã
å°é¢šã¢ãã«
èµ€å£ã®æŠãã¯åæãæ±åã®é¢šãåŒãã ããšãããæ¹æè»ã§ç«ç
ãçºçããããšãæ¹æè»æ€éã®å€§ããªèŠå ãšèšãããŠããŸããã
èœãšãæããª
COVID-19 ãçµå±å®çããã«ãã³ãããã«ãªã£ãŠãŸããã
ã ãªãããïŒ
ããããã©
ã ãªãããïŒ
ããããã©
ãŸãå
¬å¹³ãªæªçœ®ãšãããã®ã§ã¯ãªãã ããã
ç«åŠçãªåé¡ã¯ãããšããŠãä»åŸã¡ãã£ã¢ã¯ã©ã䜿ã£ãŠããã®ãããåãããããã®ããåŸæ¥ã®åœåãªã®ãã䜵èšããã®ããWHOã«æºããã®ãã
ãããäœã§covidã¯ããããã£ã€ããšãããååãããªããšãããããã
Ω以éã¯ã©ããªããã ãã
ãã¢ã«ãã¡ãããŒã¿ãã«ãããã£ããã€ãã·ãã³ããããªãã ãããã®åé¡ã«è§£ãäžããããå¯èœæ§ã
ãŠããæšå¹Žã®åæã®ããããã³ãããã£ãŠèšèã颚éªã®ãŠã€ã«ã¹ã¯ã¿ããªã³ããã ããããããã£ãŠè©±ã«ãªã£ãã¯ãã ããã§ã¯ãæŠæŒ¢èºçãã£ãŠãªã£ãŠç«ã¡æ¶ããããªã
ãŸããŒããšå ±ã«ä»åãç«ã¡æ¶ããããããïŒ
ãŸããŒããšå ±ã«ä»åãç«ã¡æ¶ããããããïŒ
ããã¯ãã£ããããšããããäœèšé¢åãšãããïŒ"ã®ãªã·ã£ç¥è©±ã®ç¥ã®ååãªã©ãåè£ã«äžãã£ãŠãã"
ãŸãããã®å°åç±æ¥ãšã¯éããªããããªã確çã®åé¡ã ãããå¥ã®å°åã§åãå€ç°ãèµ·ãã£ããšããŠãäžæè°ããç¡ãããã ãã
ãŸãããäžåœã³ãããŠã£ã«ã¹ãããæŠæŒ¢ã³ãããŠã£ã«ã¹ãã¯å·®å¥åèŠãçããšãèšã£ãšããŠå€ç°æ ªã¯ã€ã®ãªã¹åãšãã€ã³ãåãšãåŒã¶ã®æ®éã«ãããããããã
ãŸããããªãããª
ãããããã
ããã ãèªç¥ãããŠããååããããšãð§
ç®çã¯çè§£ã§ãããã©ããããªã
æ©ããããã£ããªãð
ããã ãèªç¥ãããŠããååããããšãð§
ç®çã¯çè§£ã§ãããã©ããããªã
æ©ããããã£ããªãð
å®çŸ©ããããµãã«ããŠãããã«ããããŠãããããŒãããããã©ããäžåœãæŠæŒ¢ã®ååã ããããªãããèšå·ã«ãããã ãïŒæåã®æŠæŒ¢ãŠã€ã«ã¹ã¯ã©ãããã€ããã ãã
ä»åŸã¯ãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªãã
ã®ãªã·ã£ç¥è©±ã®ç¥ã®ååãªã©ãåè£ã«äžãã£ãŠãããã®ã®ãå€ãããã©ã³ãã瀟åãªã©ã«äœ¿çšãããŠããããšããããèŠéãããã
ããã«ã¿/ãœããŒÎ±
ã¢ã«ãã¡ãã¡ãª
ããŒã¿ããã¯ã¹
ã®ã£ã©ã³ã·ã°ã
ã®ã£ã©ã³ã©ã ã
è æèšã®ãªã¡ã¬
âŠã®ãªã·ã£æåããããããããªã
ããã«ã¿/ãœããŒÎ±
ã¢ã«ãã¡ãã¡ãª
ããŒã¿ããã¯ã¹
ã®ã£ã©ã³ã·ã°ã
ã®ã£ã©ã³ã©ã ã
è æèšã®ãªã¡ã¬
âŠã®ãªã·ã£æåããããããããªã
ã¯31æ¥ãæ°åã³ãããŠã€ã«ã¹å€ç°æ ªïŒçš®é¡ã®åç§°ã«ã€ããŠãã®ãªã·ã£èªã®ã¢ã«ãã¡ãããã䜿çšãããšçºè¡šãä»åŸãè±åœæ ªã¯ã¢ã«ãã¡ãåã¢ããªã«æ ªã¯ããŒã¿ããã©ãžã«æ ªã¯ã¬ã³ããã€ã³ãæ ªã¯ãã«ã¿ãšãªãã
é
ãã£ããã©ãã©ãããé³é ããšã£ãŠå§ããããšãå
ã倧åã
ãã€ããªããåã¯ãã¢ã«ãã¡-ãã«ã¿ãïŒãããšããã€ãã·ãã³ãïŒ
ç¥æ§ã®ååã ã£ããšããããããã¹æ ªãã¯ã€ã€ã ãªã
ç¥æ§ã®ååã ã£ããšããããããã¹æ ªãã¯ã€ã€ã ãªã
仿޿ãããäžã«ããããããããã®ã§ã¯âŠæ®éã«B.1.1.7ã§è¯ãã§ãããã
ãããããããèªäœã¯æ§ããªããã©ãã
çºç¥¥ã¯äžåœæŠæŒ¢ã§ããïŒ
ã€ã®ãªã¹æ ªã¯ããŒã¿ã ããããã
æŠæŒ¢çºç¥¥ãé ãæå³ããèŠãããªã
çºç¥¥ã¯äžåœæŠæŒ¢ã§ããïŒ
ã€ã®ãªã¹æ ªã¯ããŒã¿ã ããããã
æŠæŒ¢çºç¥¥ãé ãæå³ããèŠãããªã
æŠæŒ¢èºç
ã€ã®ãªã¹å
ã€ã³ãå
ãããã å
ã€ã®ãªã¹å
ã€ã³ãå
ãããã å
ãããªåããã«ããäºããã§ãã倧å
ããäžåœãŠã€ã«ã¹ã»äžå
±ãŠã€ã«ã¹ã»æŠæŒ¢ãŠã€ã«ã¹ã»æŠæŒ¢èºçã»æŠæŒ¢ç±ãçã«ããã°ããã ãã
äŸ
倧å ïŒæŠæŒ¢ãŠã€ã«ã¹
å€ç°æ ªïŒæŠæŒ¢ãŠã€ã«ã¹ã€ã®ãªã¹åå€ç°æ ªç
ãã®ã»ãããã»ã©åããããããã
äŸ
倧å ïŒæŠæŒ¢ãŠã€ã«ã¹
å€ç°æ ªïŒæŠæŒ¢ãŠã€ã«ã¹ã€ã®ãªã¹åå€ç°æ ªç
ãã®ã»ãããã»ã©åããããããã
ãæŠæŒ¢ãŠã€ã«ã¹ãã£ãŠèšããšæã£ãŠã人éããå¹³æ°ã§åœåä»ãã®å€ç°æ ªã®åå䜿ã£ãŠãäºã«éåæãã£ããã ããªã
è¯ãæ¹åã ãšæãã
è¯ãæ¹åã ãšæãã
ä»åŸã¯ã®ãªã·ã£èªã®ã¢ã«ãã¡ãããã䜿çš
è±åœæ ªã¯ã¢ã«ãã¡
åã¢ããªã«æ ªã¯ããŒã¿
ãã©ãžã«æ ªã¯ã¬ã³ã
ã€ã³ãæ ªã¯ãã«ã¿â